You are using an older browser version. Please use a supported version for the best MSN experience.

AETHLON MEDICAL, INC.

NASDAQ: AEMD
1.51
-0.03
-1.95%

Sector

Healthcare

Industry

Healthcare Equipment & Supplies

Aethlon Medical, Inc. is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities. The Company's lead product is the Aethlon Hemopurifier, which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The Aethlon Hemopurifier sheds glycoproteins to treat infectious viral pathogens. In oncology indications, the Hemopurifier targets the removal of circulating exosomes, which are released to promote cancer progression and to seed the spread of metastasis. Through its subsidiary, Exosome Sciences, Inc. (Exosome), the Company is also developing exosome-based product candidates to diagnose and monitor neurological disorders and cancer.

Key People

James B. Frakes

Chief Financial Officer, Senior Vice President - Finance, Secretary

Charles J. Fisher

Chief Executive Officer

Edward G. Broenniman

Chairman of the Board

Guy F. Cipriani

Independent Director

Chetan S. Shah

Independent Director

Incorporated

1991

Employees

8

Insider Trades
  • Recent
  • All
  • Date

  • Name

  • Transaction

  • Shares

  • Price(s)

  • Value

    • 4/3/2020

    • CIPRIANI GUY F.

    • Grant

    • 23,893

    • NA

    • NA

    • 4/3/2020

    • SHAH CHETAN S

    • Grant

    • 23,893

    • NA

    • NA

    • 4/3/2020

    • FISHER CHARLES J JR

    • Grant

    • 23,893

    • NA

    • NA

    • 4/3/2020

    • JOHNSON SABRINA MARTUCCI

    • Grant

    • 23,893

    • NA

    • NA

    • 4/3/2020

    • BROENNIMAN EDWARD G

    • Grant

    • 23,893

    • NA

    • NA

    • 4/3/2020

    • BROENNIMAN EDWARD G

    • Grant

    • 929

    • NA

    • NA

    • 4/3/2020

    • JOHNSON SABRINA MARTUCCI

    • Grant

    • 929

    • NA

    • NA

    • 4/3/2020

    • FISHER CHARLES J JR

    • Grant

    • 929

    • NA

    • NA

    • 4/3/2020

    • SHAH CHETAN S

    • Grant

    • 929

    • NA

    • NA

    • 4/3/2020

    • CIPRIANI GUY F.

    • Grant

    • 929

    • NA

    • NA

    • Date

    • Name

    • Transaction

    • Shares

    • Price(s)

    • Value

      • 4/3/2020

      • CIPRIANI GUY F.

      • Grant

      • 23,893

      • NA

      • NA

      • 4/3/2020

      • SHAH CHETAN S

      • Grant

      • 23,893

      • NA

      • NA

      • 4/3/2020

      • FISHER CHARLES J JR

      • Grant

      • 23,893

      • NA

      • NA

      • 4/3/2020

      • JOHNSON SABRINA MARTUCCI

      • Grant

      • 23,893

      • NA

      • NA

      • 4/3/2020

      • BROENNIMAN EDWARD G

      • Grant

      • 23,893

      • NA

      • NA

      • 4/3/2020

      • BROENNIMAN EDWARD G

      • Grant

      • 929

      • NA

      • NA

      • 4/3/2020

      • JOHNSON SABRINA MARTUCCI

      • Grant

      • 929

      • NA

      • NA

      • 4/3/2020

      • FISHER CHARLES J JR

      • Grant

      • 929

      • NA

      • NA

      • 4/3/2020

      • SHAH CHETAN S

      • Grant

      • 929

      • NA

      • NA

      • 4/3/2020

      • CIPRIANI GUY F.

      • Grant

      • 929

      • NA

      • NA

      AdChoices
      AdChoices
      AdChoices
      image beaconimage beaconimage beacon